Primary Aldosteronism LC-MS/MS-specific Cutoffs

计划入组 396 人 · 首次发布于 2023 年 7 月 25 日

Determining Paediatric Usual Values for Hormones Dosages by LC-MS/MS

计划入组 1,500 人 · 首次发布于 2024 年 11 月 19 日

LC-MS/MS 25(OH)D Status in a Large Cohort

计划入组 74,235 人 · 首次发布于 2018 年 1 月 2 日

LC-2

LC-541239

LC-30

Romark Laboratories LC

Australia

MS HEALTH (PTY) LTD

South Africa

MS Ramaiah Medical College

India

Fidelio Capital Acquires Majority Stake in Alphalyse to Expand LC-MS Host Cell Protein Testing Globally

Evosep Launches High-Throughput Proteomics Platform Eno and Expands SCIEX Partnership at ASMS 2025

Breath Diagnostics Receives FDA Breakthrough Device Designation for OneBreath Platform to Assess Postoperative Pneumonia Risk